# OnCo record paper-toga-trastuzumab-gastric-lancet-2010 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-toga-trastuzumab-gastric-lancet-2010/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-toga-trastuzumab-gastric-lancet-2010" ;
  schema:name "ToGA (Bang 2010): trastuzumab with chemotherapy for HER2-positive advanced gastric cancer"@en ;
  schema:description "The trial that brought HER2 testing and trastuzumab to stomach cancer: adding the antibody to chemotherapy prolonged survival in patients whose gastric or junction cancers overexpressed HER2, about a fifth of those screened."@en ;
  schema:url <https://onco.cc/key-papers/paper-toga-trastuzumab-gastric-lancet-2010/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(10)61121-X>, <https://clinicaltrials.gov/study/NCT01041404> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(10)61121-X> ;
  schema:datePublished "2010"^^xsd:gYear ;
  schema:author "Bang YJ, Van Cutsem E, Feyereislova A, et al." ;
  onco:related <https://onco.cc/key-papers/paper-slamon-trastuzumab-nejm-2001/> ;
  onco:cancers <https://onco.cc/cancers/gastric/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/fluorouracil/> ;
  onco:companies <https://onco.cc/companies/roche-genentech/> ;
  onco:terms <https://onco.cc/terms/her2-positive/>, <https://onco.cc/terms/ihc/>, <https://onco.cc/terms/os/> ;
  onco:trials <https://onco.cc/trials/toga/> ;
  onco:people <https://onco.cc/people/bang-yung-jue/> .